Associate Director, Sales Training and Development

Remote

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates must possess a Bachelor's degree and 8-10 years of pharmaceutical sales experience, with a preference for hospital and antibiotic/infectious disease sales. A minimum of 4 years in corporate training or home office experience is preferred. Strong clinical acumen in infectious diseases, excellent facilitation, presentation, and communication skills, along with proficiency in Microsoft Office and LMS platforms, are essential. Experience with MLR systems like Veeva PromoMats and managing multiple projects in a fast-paced environment are also required.

Responsibilities

The Associate Director will design and execute training programs to enhance field force effectiveness and professional growth, collaborating with Sales Leadership, Marketing, Medical, Legal, and Compliance. Responsibilities include developing new hire and product launch training, advancing selling capabilities, strengthening coaching, managing training logistics, overseeing MLR review processes, and managing external vendors for training content creation. The role also involves evaluating training effectiveness and ensuring alignment across departments.

Skills

Sales Training

Curriculum Development

New Hire Training

Product Launch Training

Account-Based Selling

Hospital Selling

Customer-Centric Selling

Leadership Coaching

Sales Strategy

Field Execution

Competency-Based Learning

Training Evaluation

Vendor Management

Regulatory Compliance

Medical Compliance

Marketing Alignment

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free